VANGUARD GROUP INC
Q4 2023 13F-HR/A Holdings
Net value change ($000)
+506,532,511
(12.4%)
New positions
134
Sold out positions
173
Turnover %
0.6%
Sector allocation + QoQ delta (equities-only)
Holdings aggregated across other managers listed in the original SEC filing. View detailed breakdown
Snapshot: Change Analysis
Compared to Q3 2023
Methodology:
sector metrics are equities-only;
instrument mix chart is ex-options;
options exposure is shown separately.
Why this matters.
Top Adds (Value $000, Stocks/ETFs)
| MSFT | 45,045,246 | 22.0% |
| AAPL | 31,194,420 | 14.0% |
| AMZN | 20,808,040 | 21.6% |
| AVGO | 14,949,494 | 44.7% |
| NVDA | 12,677,392 | 14.3% |
| META | 10,948,295 | 19.9% |
| JPM | 6,843,312 | 17.3% |
| AMD | 6,597,436 | 45.8% |
| INTC | 5,837,391 | 43.1% |
| CRM | 5,299,304 | 31.7% |
Top Reduces (Value $000, Stocks/ETFs)
| XOM | -6,689,096 | -14.7% |
| AIY | -5,642,833 | -100.0% |
| CVX | -3,211,033 | -11.8% |
| Seagen Inc. | -2,826,059 | -100.0% |
| VMWA | -2,603,795 | -100.0% |
| Horizon Therapeutics Public Ltd Co | -2,497,451 | -100.0% |
| PFE | -2,225,527 | -13.2% |
| BUNGELTD | -1,989,285 | -100.0% |
| BMY | -1,425,520 | -12.3% |
| CSCO | -1,231,392 | -6.0% |
Instrument mix + QoQ Δ (ex-options)
How this table is calculated:
SEC
VALUE ($000) is used as reported.
For derivatives (PUT/CALL/WARRANT/RIGHT), SEC value represents reported underlying exposure, not premium cash paid/received.
Column % is bucket-based:
non-options share is calculated inside non-option total, options share is calculated inside options total.
Details.
Filter:
Instrument:
| Issuer Name | Ticker | Sector | Industry | Class | History | Value ($000) | % | Shares | Shares Δ | Shares Δ% | Value Δ ($000) | Value Δ% | Principal | Option Type |
|---|